Academia Sinica Of Taiwan, Novartis Collaborate On Medical Biotech R&D
This article was originally published in PharmAsia News
Executive Summary
Taiwan's Academia Sinica and Novartis have agreed to collaborate on medical biotechnology over the next five years, with two Taiwan researchers working with units of the Swiss-based drug maker, including in China and Singapore.